Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(360)
Martine J. Piccart
42
Virginie Durbecq
33
Christos Sotiriou
27
Angelo Di Leo
26
Fatima Cardoso
23
Journals
(46)
EJC SUPPL
8
EUR J CANCER
8
BREAST CANCER RES TREAT
7
INT J CANCER
7
ANN ONCOL
5
Keywords
(192)
Embed
Subscribe
Academic
Authors
Denis Larsimont
Denis Larsimont,University of Nottingham,Oncology,Anatomy,Pathology
Edit
Denis Larsimont
University of Nottingham
Publications:
99
|
Citations:
1581
Fields:
Oncology
,
Anatomy
,
Pathology
View FAQ about top research areas and Fields of study
Collaborated with
360 co-authors
from 1993 to 2012
|
Cited by
5660 authors
Cumulative
Annual
Sort by:
Publications
(99)
BibTeX
|
RIS
|
RefWorks
Download
Localising Prostate Cancer: Comparison of Endorectal Magnetic Resonance (MR) Imaging and 3D-MR Spectroscopic Imaging with Transrectal Ultrasound-Guided Biopsy
Maximilien C. Goris Gbenou
,
Alexandre Peltier
,
Sanjai K. Addla
,
Marc Lemort
,
Renaud Bollens
,
Denis Larsimont
,
Thierry Roumeguère
,
Claude C. Schulman
,
Roland van Velthoven
Journal:
Urologia Internationalis - UROL INT
, vol. 88, pp. 12-17, 2012
HER2Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis
,
Françoise Rothé
,
Carole Chaboteaux
,
Virginie Durbecq
,
Ghizlane Rouas
,
Carmen Criscitiello
,
Jessica Metallo
,
Naima Kheddoumi
,
Sandeep K. Singhal
,
Stefan Michiels
,
Isabelle Veys
,
José Rossari
Denis Larsimont
http://academic.research.microsoft.com/io.ashx?type=5&id=55668329&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 6, no. 1, 2011
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
Angelo Di Leo
,
Christine Desmedt
,
John M S Bartlett
,
Fanny Piette
,
Bent Ejlertsen
,
Kathleen I Pritchard
,
Denis Larsimont
,
Christopher Poole
,
Jorma Isola
,
Helena Earl
,
Henning Mouridsen
,
Frances P O'Malley
http://academic.research.microsoft.com/io.ashx?type=5&id=49598296&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
Lancet Oncology - LANCET ONCOL
, vol. 12, no. 12, pp. 1134-1142, 2011
Metasin-BLNA: The NHS Solution Cost Effective-Rapid Intraoperative Molecular Assessment of Sentinel Lymph Nodes from Breast Cancer Patients
Vasi Sundaresan
,
S. Al-Ramadhani
,
P. Balaraman
,
S. Holt
,
R. Mansel
,
I. Cree
,
D. Larsimont
,
R. Salgado
Journal:
Ejso
, vol. 37, no. 5, pp. S10-S10, 2011
Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet
C. Philippson
,
S. Simon
,
C. Vandekerkhove
,
I. Veys
,
D. Noterman
,
D. Hertens
,
F. De Neubourg
,
D. Larsimont
,
P. Van Houtte
,
J.-M. Nogaret
Journal:
Cancer Radiotherapie - CANCER RADIOTHER
, vol. 15, no. 6, pp. 560-560, 2011
Sort by:
Citations
(1581 times by 1267 publications)
How Reliable Is Ki67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast and Gynecopathologists
Zsuzsanna Varga
,
Joachim Diebold
,
Corina Dommann-Scherrer
,
Harald Frick
,
Daniela Kaup
,
Aurelia Noske
,
Ellen Obermann
,
Christian Ohlschlegel
,
Barbara Padberg
,
Christiane Rakozy
,
Sara Sancho Oliver
,
Sylviane Schobinger-Clement
http://academic.research.microsoft.com/io.ashx?type=5&id=57404875&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 5, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Caryn S. Ross-Innes
,
Rory Stark
,
Andrew E. Teschendorff
,
Kelly A. Holmes
,
H. Raza Ali
,
Mark J. Dunning
,
Gordon D. Brown
,
Ondrej Gojis
,
Ian O. Ellis
,
Andrew R. Green
,
Simak Ali
,
Suet-Feung Chin
http://academic.research.microsoft.com/io.ashx?type=5&id=56632026&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
Nature
, vol. 481, no. 7381, pp. 389-393, 2012
A refined molecular taxonomy of breast cancer
M Guedj
,
L Marisa
,
A de Reynies
,
B Orsetti
,
R Schiappa
,
F Bibeau
,
G MacGrogan
,
F Lerebours
,
P Finetti
,
M Longy
,
P Bertheau
,
F Bertrand
http://academic.research.microsoft.com/io.ashx?type=5&id=56651340&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
Oncogene
, vol. 31, no. 9, pp. 1196-1206, 2012
Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer
Alexandre Ho-Pun-Cheung
,
Hervé Bazin
,
Nadège Gaborit
,
Christel Larbouret
,
Patrick Garnero
,
Eric Assenat
,
Florence Castan
,
Caroline Bascoul-Mollevi
,
Jeanne Ramos
,
Marc Ychou
,
André Pèlegrin
,
Gérard Mathis
http://academic.research.microsoft.com/io.ashx?type=5&id=57406421&selfId1=2714871&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 7, 2012
Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
Anjali Tikoo
,
Vincent Roh
,
Karen G. Montgomery
,
Ivan Ivetac
,
Paul Waring
,
Rebecca Pelzer
,
Lauren Hare
,
Mark Shackleton
,
Patrick Humbert
,
Wayne A. Phillips
Journal:
PLOS One
, vol. 7, no. 5, 2012
Comments